What are the fundraising trends in the InsurTech market?
In our updated market reports, you will find everything you need
SUMMARY
We analyzed publicly disclosed equity funding rounds raised by pure-play InsurTech companies across full-year 2024, full-year 2025, and year-to-date 2026. The tracker only includes companies where more than 80% of the business is dedicated to insurance technology, and it excludes debt-only rounds, acquisitions, undisclosed rounds, public-company financings, and companies where insurance is only an adjacent customer vertical.
The InsurTech market rebounded sharply in the freshest period. Year-to-date 2026 funding reached about $1.54B across 27 deals, versus about $364M across 18 deals over the comparable period in 2025.
The rebound should not be read as a broad boom. Alan and Corgi alone represented roughly 60% of year-to-date 2026 capital, which means the headline growth is being driven by a small number of very large winners rather than evenly distributed funding across the whole InsurTech market.
The cleaner full-year comparison shows that 2025 was a reset year. Full-year 2025 funding fell to about $620M from about $1.08B in 2024, even though deal count rose from 32 to 37, meaning investors stayed active but wrote smaller checks.
Round sizes increased materially in 2026. The median round rose to $30M in year-to-date 2026 from $16.5M over the comparable period in 2025, while the average round rose from about $20M to $57M.
Capital is moving toward later-stage and proven companies. Series B and later rounds captured 71.9% of year-to-date 2026 capital, and follow-on financings captured 83.1% of capital.
New startup formation is still active. First financings represented 29.6% of year-to-date 2026 deals and 16.9% of capital, a much stronger capital share than the 5.8% seen over the comparable period in 2025.
Digital Insurance Brokers are the clear capital winner in 2026. The category captured 75.0% of year-to-date 2026 funding, while Insurance Core Systems and Underwriting Automation together accounted for more than half of deal count.
The InsurTech market is becoming geographically concentrated around North America and Europe. Together, those two regions captured essentially all year-to-date 2026 capital, while Asia-Pacific, Latin America, and Africa had no qualifying disclosed rounds in the supplied public evidence.
The main market shift is from digitizing insurance purchase flows toward rebuilding the operating layer of insurance. Investor attention is moving toward AI-native brokerage, underwriting infrastructure, core insurance workflows, regulated distribution, and full-stack insurance platforms.
Is more or less capital going into the InsurTech market?
More capital is going into the InsurTech market in the freshest period, but the longer full-year comparison shows that the market had contracted before the 2026 rebound. Year-to-date 2026 funding reached about $1.54B across 27 deals, versus about $364M across 18 deals over the comparable period in 2025. That is roughly 4.2x more capital and 50% more deals.
The 2026 increase is real, but it is not evenly distributed. Alan's $550M Series G alone represented 35.7% of all year-to-date 2026 capital. Corgi raised $374M across three disclosed rounds in the same period. Together, Alan and Corgi represented roughly 60% of all InsurTech funding so far in 2026.
The cleaner full-year comparison gives the necessary context. Full-year 2025 funding was about $620M, down from about $1.08B in 2024, even though deal count rose from 32 to 37. That means 2025 was not a collapse in activity; it was a smaller-check year.
The strongest interpretation is that the InsurTech market cooled in 2025 and then snapped back sharply in 2026 as large checks returned. Capital is clearly coming back into the InsurTech market, but the money is concentrating in companies that own regulated distribution, full-stack insurance economics, underwriting workflows, or core insurance operations.
Is InsurTech funding activity driven by more deals or larger rounds?
InsurTech funding activity is currently being driven by both more deals and larger rounds, but larger rounds are the stronger driver of the rebound. Deal count increased from 18 deals over the comparable period in 2025 to 27 deals in year-to-date 2026. Capital increased much faster, from about $364M to about $1.54B.
The average round size shows why the capital increase is not just a function of deal count. The average year-to-date 2026 round was about $57M, compared with about $20M over the comparable period in 2025. The median round also rose from $16.5M to $30M, which means the typical disclosed round became larger too.
The average still needs caution because the biggest rounds distort the market. Alan's $550M round was 18.3x the median round size, and the top 3 rounds captured 53.1% of total year-to-date 2026 capital. That makes the market more active, but also more concentrated.
The full-year comparison points in the opposite direction for 2025. From 2024 to 2025, deal count rose from 32 to 37 while total capital fell from about $1.08B to about $620M. So 2025 was driven by more smaller rounds, while 2026 is being driven by more deals plus much larger checks.
Is InsurTech capital moving toward later-stage or earlier-stage companies?
InsurTech capital is moving back toward later-stage companies in 2026, even though early-stage funding remains meaningful. Year-to-date 2026 late-stage rounds, defined as Series B and later, captured about $1.11B, or 71.9% of total capital. Seed and Series A rounds captured about $366M, or 23.8%.
The comparable 2025 period was even more late-stage by share, with Series B and later rounds capturing 82.8% of capital. But the absolute early-stage increase in 2026 is important: Seed and Series A capital rose from about $31M over the comparable 2025 period to about $366M in year-to-date 2026.
The stage mix shows that the market is not only late-stage because of Alan. Series B alone captured $482M, or 31.3% of year-to-date 2026 capital. Series A had 8 deals, the largest deal count of any stage, while Series B had 7 deals.
The better interpretation is that capital is moving toward validated companies, but not exclusively mature companies. Investors are funding new insurance-native AI, brokerage, underwriting, and workflow companies, but the biggest checks are going to platforms with stronger evidence of scale, regulatory readiness, carrier access, or distribution control.
Is the InsurTech market maturing or still experimental?
The InsurTech market is maturing, but it remains experimental at the formation layer. In year-to-date 2026, late-stage rounds captured 71.9% of capital, while Seed and Series A rounds represented 55.5% of deals. That combination means most dollars are going to more proven companies, while most company activity still includes early-stage experimentation.
The full-year comparison reinforces the same point. In 2025, Seed rounds were 40.5% of deals but only 13.7% of capital, and first financings were 43.2% of deals but only 14.2% of capital. That is a classic experimental formation layer: many new companies, but relatively small checks.
Where the InsurTech market is maturing, it is maturing around business models with direct insurance economics. Alan, Corgi, Lassie, Indigo, Sixfold, Artificial Labs, Honeycomb, Pace, and Yuzu Health are not generic software companies with insurance customers. They touch regulated products, underwriting workflows, broker operations, policy administration, claims-adjacent infrastructure, care navigation, or plan administration.
The market is not mature in the sense of being evenly capitalized. Claims Automation Software, Usage Based Insurance, and Fraud Detection Tools had no qualifying pure-play disclosed rounds in year-to-date 2026, and Parametric Insurance had only one. The InsurTech market is maturing around a narrower set of credible models, not across every historical InsurTech category.
Are new startups still entering the InsurTech market?
Yes, new startups are still entering the InsurTech market, but new-company formation is not the main driver of capital. In year-to-date 2026, 8 of 27 deals were first financings, equal to 29.6% of deal count. Those first financings attracted about $260M, or 16.9% of capital.
The comparable 2025 period had 6 first financings out of 18 deals, or 33.3% of deal count, but those first financings captured only 5.8% of capital. So the 2026 first-financing share is slightly lower by deal count, but much stronger by capital share.
The quality of the new entrants matters. Corgi launched with $108M, Gyde launched with $60M, Harper raised a $47M combined seed and Series A, Fulcrum raised $25M, and Pace raised a $10M Series A. These are not casual seed-stage experiments; they are heavily sponsored attempts to create new insurance platforms quickly.
The strongest conclusion is that new startups are still entering the InsurTech market, but investors are selective about which new companies receive meaningful capital. The most fundable new companies are attacking underwriting labor, brokerage productivity, commercial risk placement, insurance back-office workflows, cloud outage risk, health plan infrastructure, and regulated distribution.
Are more investors entering the InsurTech market?
More investors appear to be entering or re-entering the InsurTech market in 2026, but the strongest evidence is renewed high-quality participation rather than indiscriminate broadening. Year-to-date 2026 had approximately 110 unique disclosed investors, compared with approximately 65 over the comparable period in 2025.
The tier-1 investor count also increased. Year-to-date 2026 had 31 unique tier-1 investors, compared with approximately 18 over the comparable period in 2025. The 2026 roster includes Sequoia Capital, Lightspeed, CRV, Foundation Capital, Bessemer Venture Partners, Salesforce Ventures, General Catalyst, TCV, Thrive Capital, Index Ventures, Balderton Capital, Emergence Capital, Y Combinator, Peak XV, and several insurance-specialist or strategic investors.
The full-year comparison is more cautious. Full-year 2025 had approximately 100 unique investors and about 28 tier-1 investors, down from approximately 130 unique investors and 39 tier-1 investors in 2024. That means investor breadth narrowed in 2025 before rebounding in 2026.
The best interpretation is that investor participation is broadening again, but only around stronger themes. More investors are participating in the InsurTech market when companies show insurance-native workflows, carrier relevance, regulated distribution, underwriting expertise, or full-stack operating control.
Are top investors getting more or less active in InsurTech?
Top investors are getting more active in the InsurTech market in 2026, especially compared with the same period in 2025. In year-to-date 2026, Kindred Ventures appeared in 3 qualifying deals, while Sequoia Capital, Optum Ventures, Crystal Venture Partners, Oliver Jung, American Family Ventures, Emergence Capital, TCV, and GSBackers each appeared in 2.
Repeat activity over the comparable 2025 period was thinner. IA Capital Group clearly appeared in 2 qualifying deals, but the broader repeat pattern among top investors was much less pronounced. The 2026 market has more recognizable names and more repeated exposure.
The more important shift is that top investors are not only backing late-stage companies. Sequoia backed Pace, Lightspeed led Gyde, Emergence backed Harper and Pace, CRV and Foundation Capital backed Fulcrum, and General Catalyst backed Yuzu Health. That suggests top investors are trying to define the next operating layer of insurance rather than merely recycling capital into old winners.
The best reading is that top-investor activity is rising, but it is highly selective. The most active top investors are concentrating on AI-native brokerage, underwriting infrastructure, core insurance operations, full-stack carrier models, and regulated insurance platforms.
Which InsurTech subcategories are gaining momentum?
Digital Insurance Brokers, Insurance Core Systems, and Underwriting Automation are the subcategories gaining the clearest momentum in the InsurTech market. In year-to-date 2026, Digital Insurance Brokers captured about $1.16B, or 75.0% of total capital, across 10 deals. Insurance Core Systems captured about $185M across 7 deals, while Underwriting Automation captured about $178M across 7 deals.
The freshest comparison makes the shift especially clear. Over the comparable 2025 period, Digital Insurance Brokers captured about $212M across 6 deals. In year-to-date 2026, that category grew to more than $1.15B and 10 deals, driven by companies such as Alan, Corgi, Lassie, Gyde, Harper, Equal Parts, Novella, and Wopta.
Insurance Core Systems had one of the strongest category accelerations. The category moved from about $10M across 2 deals over the comparable 2025 period to about $185M across 7 deals in year-to-date 2026. That is a strong signal that insurance back-office infrastructure and AI-native operating systems have become fundable venture themes.
Underwriting Automation also strengthened sharply, rising from about $8M across 2 comparable-period 2025 deals to about $178M across 7 year-to-date 2026 deals. Indigo, Sixfold, Artificial Labs, Comeryx, Qumis, Greenhouse Specialty, and Honeycomb show that underwriting remains a high-conviction problem area.
Which InsurTech subcategories are losing momentum?
Claims Automation Software, Usage Based Insurance, Parametric Insurance, Embedded Insurance Platforms, and Fraud Detection Tools are losing relative momentum in the InsurTech market, at least in the public pure-play funding evidence through early July 2026. Claims Automation Software, Usage Based Insurance, and Fraud Detection Tools had no qualifying disclosed year-to-date 2026 rounds.
Claims Automation Software is the sharpest reversal. The category raised about $147M across 5 deals in 2024 and about $48M across 5 deals in 2025. Over the comparable 2025 period, it had about $29M across 3 deals. In year-to-date 2026, it had no qualifying pure-play disclosed rounds.
Usage Based Insurance also weakened. The category raised about $68M across 2 deals in 2025 and represented 18.6% of capital over the comparable 2025 period, but it had no qualifying disclosed year-to-date 2026 rounds.
Embedded Insurance Platforms have lost the leadership they had in 2024. The category raised about $241M in 2024, about $35M in 2025, and only about $20M across 2 year-to-date 2026 deals. Embedded insurance has not disappeared, but it is no longer the dominant venture theme it was when scaled embedded platforms were absorbing larger checks.
Which regions are gaining momentum in InsurTech funding?
North America and Europe are both gaining momentum in the InsurTech market in 2026, but they are gaining momentum in different ways. North America is gaining by deal breadth, while Europe is gaining through larger average round size and a few very large winners.
North America had 20 year-to-date 2026 deals and about $816M of capital. Over the comparable period in 2025, North America had 13 deals and about $206M. That means North American deal count rose by more than 50%, while capital rose nearly 4x.
Europe's gain is even more dramatic in capital terms. Europe had about $722M in year-to-date 2026 funding, compared with about $50M over the comparable period in 2025. Alan's $550M round drove much of the increase, but Lassie, Artificial Labs, ManageMy, Wopta, and Kayna also contributed.
The full-year comparison shows why the regional story is volatile. Europe led capital in 2024 with about $610M, fell to about $67M in full-year 2025, and then rebounded sharply in year-to-date 2026. North America led full-year 2025 and remains the deepest formation market in 2026.
Which regions are losing momentum in InsurTech funding?
Asia-Pacific, Africa, Latin America, and the Middle East are losing relative momentum in the InsurTech market, although each region has a different story. Asia-Pacific and Africa had meaningful visibility in 2025 but no qualifying disclosed activity in year-to-date 2026. Latin America has largely disappeared from the strict public pure-play map after one 2024 deal. The Middle East appeared in 2026, but only through one small seed round.
Asia-Pacific is the most important loss of momentum. In 2024, Asia-Pacific had about $112M across 3 deals. In 2025, it had about $77M across 2 deals, including InsuranceDekho. In year-to-date 2026, Asia-Pacific had no qualifying disclosed deals in the supplied public evidence.
Africa also lost visibility. Naked's $37.5M round gave Africa 10.3% of comparable-period 2025 capital and 6.1% of full-year 2025 capital. In year-to-date 2026, there were no qualifying African InsurTech rounds.
The Middle East is present but not yet a major capital center. Mantas raised $1.77M for parametric cloud downtime insurance, but that represented only 0.1% of year-to-date 2026 capital. So the Middle East is visible, not yet scaled.
Is the InsurTech market becoming more global or more regionally concentrated?
The InsurTech market is becoming more regionally concentrated in the freshest evidence. Year-to-date 2026 capital is almost entirely concentrated in North America and Europe. North America represented 53.0% of capital and 74.1% of deals, while Europe represented 46.9% of capital and 22.2% of deals.
Together, North America and Europe represented essentially all year-to-date 2026 capital. That is more concentrated than full-year 2025, when North America represented 70.4% of capital, Asia-Pacific 12.4%, Europe 10.8%, Africa 6.1%, and the Middle East 0.3%.
The comparison with 2024 also matters. In 2024, Europe represented 56.5% of capital, North America 32.3%, Asia-Pacific 10.4%, and Latin America 0.8%. That year had a more balanced split between Europe, North America, and Asia-Pacific than the current period.
The best conclusion is that the InsurTech market is not becoming more global in the current public funding evidence. It is becoming more concentrated around North American formation and European scale rounds.
Is InsurTech capital moving toward proven winners or new opportunities?
InsurTech capital is moving primarily toward proven winners, but new opportunities are still receiving meaningful funding when they look unusually credible. In year-to-date 2026, follow-on deals represented 70.4% of deal count and 83.1% of capital. First financings represented 29.6% of deals and 16.9% of capital.
The largest 2026 rounds make the proven-winner bias clear. Alan, Corgi's follow-on rounds, Lassie, Indigo, Sixfold, Artificial Labs, ManageMy, Yuzu Health, Honeycomb, Pace's Series B, and Outmarket AI all had prior financing, customer traction, regulatory footing, or institutional validation.
New opportunities have not disappeared. In 2024, first financings represented only 15.6% of deals and 1.3% of capital. In full-year 2025, first financings rose to 43.2% of deals and 14.2% of capital. In year-to-date 2026, first financings remained economically meaningful at 16.9% of capital.
The practical reading is that ordinary early-stage experiments are still small, but exceptional new platforms can raise large amounts immediately. The InsurTech market is funding new opportunities when the company begins with a serious wedge into insurance infrastructure, underwriting, brokerage operations, or regulated distribution.
Is the InsurTech market becoming winner-takes-most?
Yes, the InsurTech market is becoming more winner-takes-most in 2026, at least in capital allocation. The largest year-to-date 2026 deal captured 35.7% of all capital, the top 3 rounds captured 53.1%, the top 5 captured 64.9%, and the top 10 captured 81.0%. The bottom half of deals captured only 9.3%.
Alan and Corgi are the clearest examples of winner-takes-most behavior. Alan's $550M round was larger than the entire comparable-period 2025 total, and Corgi raised $374M across three disclosed rounds in the same year-to-date 2026 window.
The full-year comparison adds nuance. The InsurTech market became less concentrated in 2025 than it had been in 2024. In 2024, the top 10 deals captured 77.6% of capital. In 2025, the top 10 captured 60.7%. The winner-takes-most pattern returned in 2026.
The key distinction is that the InsurTech market is winner-takes-most by dollars, not by company count. There were still 27 year-to-date 2026 deals across 24 unique companies, so activity is broad. But the largest checks are clustering around a small number of companies that investors believe could become dominant platforms.
Is the next wave of InsurTech winners becoming visible?
Yes, the next wave of InsurTech winners is becoming visible, but it is visible more by category pattern than by guaranteed company outcomes. The strongest next-wave pattern is AI-native insurance operations, underwriting automation, full-stack insurance, and broker-led distribution.
The likely next-wave candidates cluster into three groups. The first group is full-stack or distribution-led insurance platforms such as Alan, Corgi, Lassie, Gyde, Harper, Equal Parts, Novella, Wopta, and Honeycomb. These companies directly touch customer acquisition, risk selection, policy placement, or regulated insurance operations.
The second group is AI-native insurance operations and core-system platforms such as Pace, Fulcrum, ManageMy, Yuzu Health, Outmarket AI, and General Magic. This group shows investor attention shifting toward back-office infrastructure, broker workflows, policy administration, and health plan administration.
The third group is underwriting infrastructure, including Indigo, Sixfold, Artificial Labs, Comeryx, Qumis, Greenhouse Specialty, and Honeycomb. These companies sit close to risk selection, pricing, coverage analysis, and specialty insurance workflows, which are economically central to insurance outcomes.
The strongest conclusion is that the next wave of winners will own insurance-specific workflows that matter to loss ratio, expense ratio, distribution conversion, or administrative throughput. Generic AI applied to insurance language is a much weaker signal than deep workflow ownership.
Is the InsurTech funding landscape fragmenting or consolidating?
The InsurTech funding landscape is fragmenting at the company-formation layer but consolidating at the capital-allocation layer. Year-to-date 2026 had 27 deals across 24 unique companies, which shows broad activity. But the top 5 deals captured 64.9% of capital, which shows heavy concentration of dollars.
Fragmentation is visible in the number of funded themes. The market includes AI brokerage, full-stack startup insurance, pet insurance, health insurance infrastructure, underwriting automation, E&S brokerage, cloud outage parametric insurance, embedded benefits infrastructure, policy servicing, and brokerage operations.
Consolidation is visible in the largest checks. Alan, Corgi, Lassie, Gyde, Indigo, Pace, Artificial Labs, ManageMy, Honeycomb, and Harper absorbed a large share of total dollars. Those are the companies investors are treating as more likely to scale.
The best interpretation is that InsurTech is fragmenting in ideas but consolidating in financial power. Many companies can still raise money, but only a few are receiving enough capital to become platform-scale contenders.
Where is investor attention shifting in InsurTech?
Investor attention in the InsurTech market is shifting toward insurance-native AI, regulated distribution, underwriting infrastructure, and core operating systems for insurers and brokers. Year-to-date 2026 Digital Insurance Brokers captured 75.0% of capital, while Insurance Core Systems and Underwriting Automation together captured 51.9% of deals.
The shift is away from older standalone InsurTech narratives. Embedded Insurance Platforms raised about $241M in 2024 but only about $20M in year-to-date 2026. Claims Automation Software, Usage Based Insurance, and Fraud Detection Tools had no qualifying pure-play year-to-date 2026 deals.
The stage evidence reinforces the shift. Series A and Series B together accounted for 15 of 27 year-to-date 2026 deals and $765M of capital. That is classic next-platform-layer funding behavior: investors are backing companies that have moved beyond formation but are still early enough to define new categories.
The strongest reading is that investor attention is moving from making insurance digital to making insurance operating systems intelligent. The center of gravity is now risk selection, broker productivity, policy administration, underwriting judgment, regulated distribution, and automation of expensive insurance labor.
INSIGHTS
The insights below come from reviewing disclosed equity funding rounds in the pure-play InsurTech market across full-year 2024, full-year 2025, and year-to-date 2026.
- The 2026 InsurTech rebound is real, but the rebound is not evenly distributed. Year-to-date 2026 capital is more than 4x the comparable 2025 period, yet Alan and Corgi together explain roughly 60% of total dollars.
- Full-year 2025 was not a failure year for InsurTech; it was a smaller-check year. Deal count rose from 32 in 2024 to 37 in 2025, while capital fell from about $1.08B to about $620M, which means investors kept funding the market but reduced round intensity.
- The cleanest sign of renewed investor conviction in 2026 is the rise in both average and median round size. Average round size rose from about $20M over the comparable 2025 period to about $57M in year-to-date 2026, while median round size rose from $16.5M to $30M.
- The InsurTech market is no longer mainly about making insurance easier to buy online. The strongest 2026 funding patterns point to underwriting, brokerage operations, core systems, full-stack insurance, and AI-enabled administrative infrastructure.
- Digital Insurance Brokers regained capital dominance because the category now includes scaled, complex, and regulated insurance platforms, not just comparison websites. Alan, Corgi, Lassie, Gyde, Harper, Novella, and Honeycomb show that digital distribution is most fundable when it is tied to risk, workflow, or carrier economics.
- Insurance Core Systems is one of the most important emerging categories because it moved from about $10M over the comparable 2025 period to about $185M in year-to-date 2026. This suggests insurance back-office infrastructure has become a credible venture theme rather than only a slow enterprise replacement cycle.
- Underwriting Automation has broad deal momentum but lower capital density than Digital Insurance Brokers. Investors clearly like the problem area, but the largest checks still go to companies that combine underwriting advantage with distribution, regulated capacity, or platform scope.
- Claims Automation Software's disappearance from the year-to-date 2026 pure-play funding list is a warning against assuming that every insurance workflow automation category benefits equally from AI enthusiasm. Claims may be active operationally, but standalone claims automation did not attract visible qualifying public equity rounds in the supplied evidence.
- Embedded insurance has lost the narrative leadership it had in 2024. The category raised about $241M in 2024, about $35M in 2025, and only about $20M in year-to-date 2026, which suggests the market has become more skeptical of embedded distribution unless scale is already proven.
- Parametric Insurance remains strategically logical but venture-thin in the public evidence. The category went from $75M in 2024 to $28M in 2025 to only $1.77M in year-to-date 2026, suggesting the idea is attractive but hard to scale into repeat venture financings.
- Fraud Detection Tools are conspicuously absent across the strict pure-play mapping. The likely interpretation is not that fraud is irrelevant, but that fraud is being absorbed into underwriting, claims, and broader risk platforms rather than funded as a standalone InsurTech category.
- The InsurTech market's center of gravity has moved from front-end digitization to economic control points. Investors are funding companies that influence loss ratio, expense ratio, distribution conversion, administrative throughput, or regulated product design.
- North America remains the formation engine of the InsurTech market. In year-to-date 2026, North America produced 74.1% of deals, far above Europe's 22.2%, even though Europe nearly matched North America in capital because Alan was so large.
- Europe's 2026 signal is capital-heavy but company-light. Europe produced about $722M across 6 deals, meaning the region's momentum depends on a small number of larger, more mature companies rather than a broad formation surge.
- Asia-Pacific's absence in year-to-date 2026 is a meaningful reversal from 2024 and 2025. The region had bolttech and InsuranceDekho as major prior contributors, but no qualifying disclosed year-to-date 2026 rounds in the supplied public pure-play evidence.
- The highest-quality first financings in 2026 look more like institutional platform launches than ordinary seed rounds. Corgi, Gyde, Harper, Fulcrum, and Pace raised large initial rounds because they entered the market with ambitious regulated or workflow-heavy models.
- The InsurTech market is winner-takes-most in capital but not in company count. There are many funded companies, but a small number of companies absorb most of the dollars.
- The return of megarounds is one of the clearest differences between 2025 and 2026. Full-year 2025 had only one round above $50M, while year-to-date 2026 already had six rounds above $50M and four rounds above $100M.
- The strongest rounds often combine two validation layers: a top-tier generalist investor and an insurance-sector investor or strategic partner. This combination is a stronger credibility signal than either valuation or round size alone.
- AI has become a funding accelerant, but only when it is insurance-native. The strongest 2026 AI-related rounds are attached to underwriting, brokerage operations, policy administration, health plan administration, and insurance back-office workflows, not generic horizontal AI tools.
- A practical future screening rule is that an InsurTech startup deserves more weight when it can show one of four things: regulated distribution control, underwriting advantage, insurance workflow ownership, or carrier and strategic validation. Without at least one of those, the company is more likely to sit in the long tail than become a next-wave winner.
OUR METHODOLOGY TO BUILD THIS TRACKER
We built this InsurTech funding tracker by reviewing publicly disclosed equity rounds raised by pure-play InsurTech companies across full-year 2024, full-year 2025, and year-to-date 2026. A company counts as pure-play when more than 80% of its activity is dedicated to technology products that help insurance companies, brokers, and customers price, sell, manage, administer, underwrite, or claim policies.
We applied four main filters to build the tracker. First, we only included equity rounds or equity-like growth financings where the equity component was disclosed or could be reasonably separated. Second, we only counted rounds of $300K or more. Third, we only kept pure-play InsurTech companies, excluding broad horizontal AI vendors, generic healthcare providers, satellite or data companies not primarily built for insurance, and brokers or carriers whose financing was not technology-led. Fourth, each included round had to be supported by a direct company announcement, press release, tier-1 media report, specialist insurance source, or relevant regional publication.
We excluded debt-only facilities, acquisitions, public-company financings, undisclosed-amount rounds, and private regulatory filings without enough product detail to confirm pure-play InsurTech exposure. Undisclosed-amount rounds are excluded because including them would distort dollar-based metrics such as total capital, average round size, category share, regional share, and concentration ratios. Currency conversions are approximate when original sources reported non-USD amounts, and mixed debt-equity financings are counted only for the estimated equity component when that distinction is available.
Related blog posts
- Which companies have raised the most funding in the InsurTech market?
- Which companies are the most valued in the InsurTech market?
